Effects of thiazolidinediones on cardiovascular risk factors.
The thiazolidinediones are the insulin sensitizers used in the management of Type 2 diabetes mellitus. These drugs can potentially decrease the risk of cardiovascular disease by correcting the different components of the insulin resistance syndrome.
Gouda
Biswanath P
BP
Department of Medicine, Section of Endocrinology, Tulane University Health Sciences Center, New Orleans, LA, USA.
Asnani
Sunil
S
Fonseca
Vivian A
VA
D001161:Arteriosclerosis / Q000150:complications / Q000188:drug therapy; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D005342:Fibrinolysis / Q000502:physiology; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007333:Insulin Resistance / Q000502:physiology; D012307:Risk Factors; D013844:Thiazoles / Q000494:pharmacology*; D014655:Vascular Resistance / Q000187:drug effects; D015430:Weight Gain / Q000187:drug effects
D007004:Hypoglycemic Agents; D013844:Thiazoles